Thoracic Duct Embolization for Chylothorax

Introduction to Thoracic Duct Embolization

The American College of Radiology recommends thoracic duct embolization (TDE) as the first-line invasive treatment for high-output chylothorax, with clinical success rates up to 97% and significantly lower morbidity compared to surgical ligation 1, 2

The diagnosis of chylothorax should be confirmed through pleural fluid analysis with the following criteria: pleural fluid triglyceride level >110 mg/dL, ratio of pleural fluid to serum triglyceride level >1.0, and ratio of pleural fluid to serum cholesterol level <1.0 1, 3

The American College of Radiology suggests that conservative management should be initiated for all patients, including dietary modifications, total parenteral nutrition, and adjunctive pharmacotherapy, with a success rate of approximately 50% in nonmalignant cases 1, 3
The Society of Interventional Radiology recommends proceeding to TDE when conservative management fails after 2 weeks, with high output >500-1000 mL/day, or in cases of underlying neoplastic etiology 1, 3

The technical success rate of TDE is 85-88.5% across all causes, with clinical success rates of 90-97% for traumatic leaks and 72% for nontraumatic leaks 1, 2, 4
The American College of Radiology reports that TDE demonstrates higher clinical success in traumatic versus nontraumatic leaks 2, 3

The incidence of acute complications after TDE is 2-6%, with generally minor and self-limited complications, while long-term complications occur in up to 14% of patients, including leg swelling, abdominal swelling, and chronic diarrhea 1, 2, 3, 4

The American College of Radiology recommends TDE as the first-line interventional approach for pediatric cardiac surgery patients, with the same high success rates as in adults 4
In cases of malignancy-related chylothorax, more aggressive early intervention is required, and indwelling pleural catheters can be used without significant increase in infection or albumin loss 2